Samsung Hearapy App and Motion Sickness: The Science Explained

Samsung quietly released a free Android app this week called Hearapy that plays a single low-frequency tone and claims to reduce motion sickness symptoms for up to two hours from a single minute of listening. The pitch sounds almost too simple. The research behind the Samsung Hearapy app motion sickness claim is real and specific enough to take seriously, while also being narrow enough to misread.

Hearapy is built on one peer-reviewed study from Nagoya University, published in Environmental Health and Preventive Medicine in 2025 (doi.org/10.1265/ehpm.24-00247), that found a 100Hz tone reduced motion sickness symptoms in controlled scenarios. The central question isn't whether the science exists. It does. The question is whether a consumer app running through everyday earbuds can reproduce the conditions that made it work.

Samsung launched the app without a major product event, describing it as a soft rollout available free on the Google Play Store, Android Police reported this week. Availability is currently limited to South Korea, per NewsBytes.

How Hearapy works: a one-feature app with a specific mechanism

The app is bare-bones by design. Users put on headphones, tap to start, and let a built-in timer run the session. Samsung's published guidance cites 60 seconds as the standard dose, though Android Authority found the in-app timer actually ran 90 seconds when tested. Android Police reports playback can run up to 120 seconds maximum, and users can repeat as needed during a trip.

The app targets the vestibular system, specifically the otolithic organs in the inner ear that detect linear acceleration and gravity. Samsung's VP of Marketing, quoted by Android Authority, describes the tone as allowing "better processing of movements," which closely mirrors the physiological explanation in the source research.

Samsung recommends listening at approximately 85 dB, loud but not uncomfortable, and suggests its Galaxy Buds 4 Pro for the cleanest bass output. NewsBytes notes that any earbuds capable of reproducing 100Hz should work in principle. The app has no built-in mechanism to verify actual output level on a given device.

Samsung frames Hearapy as a way to avoid the drowsiness and other side effects commonly associated with over-the-counter motion sickness medication, per Android Police. That framing is credible as a benefit of the approach, as long as the approach works, which is the part that needs scrutiny.

The app matches the Nagoya study's core parameters: same frequency, similar volume, similar duration. What remains uncertain is whether ordinary earbuds can reproduce the studied stimulus closely enough to matter, given that the original research used a controlled audio stimulus at a verified volume level, not consumer hardware with variable bass response, fit, and seal.

Samsung Hearapy app for motion sickness: what the Nagoya study actually found

Researchers Takumi Kagawa and Masashi Kato at Nagoya University Graduate School of Medicine tested participants across three scenarios after brief tone exposure: a physical swing, a driving simulator, and actual car rides. They measured postural control, ECG and heart rate variability, and standardized Motion Sickness Assessment Questionnaire scores, per News-Medical last year. The study's title signals its scope precisely: "Just 1-min exposure to a pure tone at 100 Hz with daily exposable sound pressure levels may improve motion sickness" a claim about a bounded condition, not a broad cure.

A single minute of 100Hz exposure reduced lightheadedness and nausea, and improved sympathetic nerve regulation, the autonomic function often disrupted in motion sickness. Kato described the result as "objectively improved" based on ECG data, per Lab Manager last year. Kagawa noted that sound levels fell within everyday environmental noise ranges, characterizing the approach as both effective and safe for short-term use.

Using both mouse models and human participants, the Nagoya team tested multiple frequencies and identified 100Hz as the optimal point for stimulating the otolithic organs. At that frequency, the vibration appears to broadly activate the vestibular system rather than triggering it in a disruptive way, ScienceDaily reported last year.

What the study does not establish:

• It does not confirm that the intervention works across air, sea, or bus travel
• It does not specify how well the effect translates when delivered through consumer earbuds with variable bass response, fit, and seal
• The two-hour relief window appears in the study's findings but was measured under controlled conditions, not confirmed through real-world testing of the app itself, per Android Police and Android Authority; Samsung cites this figure as a product claim, but it carries the weight of lab data, not consumer evidence
• The Nagoya team noted plans to extend the research toward additional travel contexts, a signal that even the original researchers view car-ride scenarios as a starting point, not universal proof, per News-Medical

This is real, peer-reviewed science with a plausible mechanism and measurable outcomes. What Samsung has done is apply those findings in conditions the study wasn't designed to validate. That's either a reasonable first step or an overstep, depending on how the app is positioned.

What Samsung is extrapolating and where the evidence runs out

The Nagoya study used a controlled audio stimulus at a verified volume level. Hearapy runs on any Android phone through any headphones. Low-frequency bass response varies significantly between earbud models; how well a given pair reproduces 100Hz at 85 dB depends on driver size, fit, and seal, none of which the app can assess or compensate for. Samsung's recommendation of the Galaxy Buds 4 Pro for "clean and powerful 100Hz sound," per Android Authority, implicitly acknowledges this gap without resolving it for the majority of users who won't use that specific hardware.

Multiple outlets, including GSMArena, used the word "cure" in their coverage this week. The Nagoya researchers used "alleviates" and "reduces." That distinction matters: the study measured symptom mitigation in specific, bounded scenarios, not elimination of motion sickness across all contexts. Samsung's own marketing favors "relief," but the coverage gap reflects how easily a qualified scientific claim gets stripped of its qualifications in transit.

Hearapy has not been independently tested as a consumer product. There are no published trials of the app under real travel conditions, no systematic data on which earbuds perform adequately at the required frequency, and no independent verification of the "up to two hours" relief figure beyond Samsung's own communications.

None of this makes Hearapy implausible. The mechanism is sound, and the source research is credible. It makes Hearapy a first-generation consumer translation of early-stage research, a meaningful difference from a clinically validated intervention, and worth being clear about.

Who should try it, and when

For anyone who gets mildly to moderately carsick, Hearapy is worth a test. Car travel is the context closest to what the Nagoya study actually examined, and the bar to try it is low: the app is free, the session takes one minute, and the risk of brief 100Hz exposure at moderate volume is minimal. Kagawa described the sound level as "well below workplace noise safety standards," per Lab Manager.

A practical breakdown:

• Best fit: mild to moderate nausea during car travel, used before the trip starts
• How to test it: snug-sealing earbuds at a comfortable-but-loud volume, not maximum output
• Least supported use cases: flights, boats, long bus or train trips, where the study provides no direct evidence
• When not to rely on it: severe motion sickness, a history of vestibular disorders, or situations where proven medication is the safer baseline

Anyone using the app should understand that the scientific support is specific, not general: one study, three road-travel scenarios, controlled conditions. Standard earbuds may or may not reproduce the required stimulus accurately enough to replicate the studied effect. That's an open question the app cannot answer for the user.

Promising enough to try, not proven enough to replace anything

The Nagoya researchers plan to extend the work toward air and sea travel, per News-Medical, which suggests the science has room to develop. Hearapy, meanwhile, is a low-cost software experiment that either quietly becomes a standard wellness feature across Galaxy devices or gets quietly retired when real-world results diverge from lab conditions. The difference between those outcomes probably depends on data Samsung is only now beginning to collect.